Gladstone NOW: The Campaign Join Us on the Journey ✕
1 - 15 of 94 Results Clear All
CRISPR Screens Map Human T‑Cell Genes That Promote or Block HIV Infection
Gladstone in the News
April 20, 2026
CRISPR Screens Map Human T‑Cell Genes That Promote or Block HIV Infection
Genetic Engineering & Biotechnology News—Work from Alex Marson’s and Nevan Krogan’s labs show that genome‑wide CRISPR screens in primary human T cells reveal human genes that promote or block HIV infection, uncovering potent antiviral factors like PI16 and PPID.
Krogan Lab Marson Lab CRISPR/Gene Editing Human Genetics HIV/AIDS ImmunologyScientists Map How HIV Hijacks Human Cells—and How Cells Can Fight Back
Article
April 20, 2026
Scientists Map How HIV Hijacks Human Cells—and How Cells Can Fight Back
A new genetic roadmap reveals hundreds of hidden players in HIV infection, including two proteins that stop HIV in its tracks.
News Release Research (Publication) HIV/AIDS Genomic Immunology Krogan Lab Marson LabamfAR Launches $2 Million AI-Enabled, Collaborative Study to Map the HIV Reservoir
Gladstone in the News
April 8, 2026
amfAR Launches $2 Million AI-Enabled, Collaborative Study to Map the HIV Reservoir
amfAR—Gladstone Investigators Melanie Ott and Nadia Roan are central to a groundbreaking effort to create the world’s first map of how HIV affects the immune system at a single-cell level. Funded by amfAR, the AI-driven project will establish a crucial scientific resource to speed the development of better treatments, and possibly a cure, for HIV.
HIV/AIDS Roan Lab Ott LabHIV Remains Suppressed in Some Patients After Treatment Withdrawal
Gladstone in the News
March 23, 2026
HIV Remains Suppressed in Some Patients After Treatment Withdrawal
Genetic Engineering & Biotechnology News—Gladstone Investigator Nadia Roan and her team are shedding light on why some people with HIV can control the virus even after stopping treatment.
Roan Lab HIV/AIDSScience in Seconds | A New Path Toward Life Without Daily HIV Pills
Video
March 20, 2026
Science in Seconds | A New Path Toward Life Without Daily HIV Pills
In this video, Nadia Roan and Ashley George explain how they uncovered a new path toward long-term health without the need for daily HIV pills.
Gladstone Experts Research (Publication) HIV/AIDS Infectious Disease Roan LabWhy Some People Naturally Control HIV Even After Stopping Therapy—and How We Can Leverage That to Treat Others
Article
March 20, 2026
Why Some People Naturally Control HIV Even After Stopping Therapy—and How We Can Leverage That to Treat Others
New research offers a path toward life without daily HIV pills, suggesting common diabetes pill could help achieve long-term remission.
News Release Research (Publication) HIV/AIDS Infectious Disease Roan LabNew Tool Reveals the Secrets of HIV-Infected Cells
Gladstone in the News
March 4, 2026
New Tool Reveals the Secrets of HIV-Infected Cells
The Microbiologist—Gladstone Investigator Nadia Roan and her team have developed a novel tool, named HIV-seq, for profiling the features of rare HIV-infected cells from people with HIV.
Gladstone Experts HIV/AIDS Infectious Disease Roan LabVirologist Viewpoints: For HIV, ‘Manageable’ Is No Longer Good Enough
Article
March 3, 2026
Virologist Viewpoints: For HIV, ‘Manageable’ Is No Longer Good Enough
Once a godsend, antiretroviral therapy is not what we should settle on. The time has come to finally cure HIV/AIDS.
HIV/AIDS Ott LabNew Tool Reveals the Secrets of HIV-Infected Cells
Article
March 3, 2026
New Tool Reveals the Secrets of HIV-Infected Cells
Developed by Gladstone scientists, HIV-seq could uncover new opportunities for treating HIV.
News Release Research (Publication) HIV/AIDS Infectious Disease Roan LabGladstone Scientist Nadia Roan Elected to American Academy of Microbiology
Article
February 20, 2026
Gladstone Scientist Nadia Roan Elected to American Academy of Microbiology
Roan has made great strides in understanding how persistent viruses including HIV cause disease and how immunity to viruses shapes human health.
Awards News Release COVID-19 HIV/AIDS Infectious Disease Roan LabOne Person’s Final Gift to Science Gets Us Closer to an HIV Cure
Article
December 19, 2025
One Person’s Final Gift to Science Gets Us Closer to an HIV Cure
A new documentary follows Jim Dunn’s end-of-life decision to donate his tissues to HIV research.
Institutional News HIV/AIDS Infectious Disease Roan LabAmfAR Awards New HIV Cure-Focused Research Grants Totaling $2.4 Million
Gladstone in the News
October 16, 2025
AmfAR Awards New HIV Cure-Focused Research Grants Totaling $2.4 Million
amfAR—Gladstone Investigator Nadia Roan and her collaborator at Stanford University are among five research teams to receive an amfAR grant for novel HIV cure strategies.
Grants HIV/AIDS Roan LabBeyond Viruses: Expanding the Fight Against Infectious Diseases
Article
September 25, 2025
Beyond Viruses: Expanding the Fight Against Infectious Diseases
The newly renamed Gladstone Infectious Disease Institute broadens its mission to address global health threats ranging from antibiotic resistance to infections that cause chronic diseases.
Institutional News News Release Cancer COVID-19 Hepatitis C HIV/AIDS Zika Virus Infectious DiseaseWith Vaccine Research Under Attack, It’s Time for California to Lead Again
Gladstone in the News
August 14, 2025
With Vaccine Research Under Attack, It’s Time for California to Lead Again
The San Francisco Standard—In this opinion piece, Melanie Ott, director of the Gladstone Institute of Virology, writes that halting mRNA research right now is like banning ChatGPT—it's not just scientific negligence, but strategic self-sabotage. She proposes ways for California to take the lead by funding crucial research at the state level.
Gladstone Experts Cancer COVID-19 HIV/AIDS Infectious Disease Ott Lab